Planned conservative management of placenta percreta

Journal of Obstetrics and Gynaecology

Volumn 32, Issue 5, 2012, Pages 447-452

  Wong, V V ^a   Burke, G ^a  

^a Mid Western Regional Hospital   (Ireland)

Author keywords

Accreta; DIC; Hysterectomy; Percreta; Placenta

Indexed keywords

ENOXAPARIN; HEMOGLOBIN; OCTAPLAS; OXYTOCIN;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; ETHNICITY; FEMALE; FEVER; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPOTHYROIDISM; HYSTERECTOMY; INFERIOR CAVA VEIN; INTENSIVE CARE; PATIENT SAFETY; PLACENTA ACCRETA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URETER STENT; UTERINE ARTERY EMBOLIZATION;

ADULT; DISSEMINATED INTRAVASCULAR COAGULATION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYSTERECTOMY; PLACENTA ACCRETA; PREGNANCY; RETROSPECTIVE STUDIES; URINARY BLADDER; UTERINE ARTERY; VENOUS THROMBOSIS;

EID: 84861808010     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2012.669429     Document Type: Article

References (27)

1. Alanis M, Hurst BS, Marshburn PB, Matthews ML. 2006. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertility Sterility 86:1514.e3-e7.
2. Angstmann T, Gard G, Harrington T, Ward E, Th omson A, Giles W. 2010. Surgical management of placenta accreta: a cohort series and suggested approaC.H. American Journal of Obstetrics and Gynecology 202:38.e1-e9.
3. Butt K, Gagnon A, Delisle MF. 2002. Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. Obstetrics and Gynecology 99:981-982.
4. Eller AG, Porter TF, Soisson P, Silver RM. 2009. Optimal management strategies for placenta accreta. British Journal of Obstetrics and Gynaecology 116:648-654.
5. Hatfi eld JL, Brumsted JR, Cooper BC. 2006. Conservative treatment of placenta accreta. Journal of Minimally Invasive Gynecology 13:510-513.
6. Heiskanen N, Kröger J, Kainulainen S, Heinonen S. 2008. Placenta percreta: methotrexate treatment and MRI fi ndings. American Journal of Perinatology 25:91-92.
7. Jaff e R, DuBeshter B, Sherer DM, Th ompson EA, Woods JR J.R. 1994. Failure of methotrexate treatment for term placenta percreta. American Journal of Obstetrics and Gynecology 171:558-559.
8. Jung HN, Shin SW, Choi SJ, Cho SK, Park KB, Park HS et al. 2011. Uterine artery embolization for emergent management of postpartum hemorrhage associated with placenta accreta. Acta Radiologica 52:638-642.
9. Karam AK, Bristow RE, Bienstock J, Montz FJ. 2003. Argon beam coagulation facilitates management of placenta percreta with bladder invasion. Obstetrics and Gynecology 102:555-556.
10. Kayem G, Davy C, Gogginet F, Th omas C, Clement D, Cabrol D. 2004. Conservative versus extirpative management in cases of placenta accreta. Obstetrics and Gynecology 104:531-536.
11. Kayem G, Pannier E, Gogginet F, Grange G, Cabrol D. 2002. Fertility aft er conservative treatment of placenta accreta. Fertility Sterility 78:637-638.
12. Kulkarni A, Draycott T. The use of serial betaHCG to plan surgical evacuation of retained placenta in a case of placenta accreta.2005. Journal of Maternal-fetal and Neonatal Medicine 17:295-297
13. Letsky EA. Disseminated intravascular coagulation. 2001. Best practice and researC.H. Clinical Obstetrics and Gynaecology 15:623-644.
14. Levine D, Barnes P, Edelman R. 1999. Obstetric MR imaging. Radiology 211:609-617.
15. Matsumura N, Inoue T, Fukuoka M, Sagawa N, Fujii S. 2000. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta. Journal of Obstetrics and Gynaecology Research 26:81-87.
16. McLean LA, Heilbrun ME, Eller AG, Kennedy AM, Woodward PJ. 2011. Assessing the role of magnetic resonance imaging in the management of gravid patients at risk for placenta accreta. Academic Radiology 18: 1175-1180.
17. Miller DA, Chollet JA, Goodwin TM. 1997. Clinical risk factors for placenta previa-placenta accreta. American Journal of Obstetrics and Gynecology 177:210-214.
18. Nishijima K, Shukunami K, Arikura S, Kotsuji F. 2005. An operative technique for conservative management of placenta accreta. Obstetrics and Gynecology 105:1201-1203.
19. O ' Brien JM, Barton JR, Donaldson ES. 1996. Th e management of placenta percreta: conservative and operative strategies. American Journal of Obstetrics and Gynecology 175:1632-1638.
20. Pacheco LD, Gei AF. 2011. Controversies in the management of placenta accreta. Obstetrics and Gynecology Clinics of North America 38: 313-322.
21. Palacios Jaraquemada JM, Bruno C.H. 2005. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new fi ndings. Acta Obstetricia et Gynecologica Scandinavica 84:716-724.
22. Robinson BK, Grobman WA. 2010. Eff ectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstetrics and Gynecology 116:835-842.
23. Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F et al. 2010. Maternal outcome aft er conservative treatment of placenta accreta. Obstetrics and Gynecology 115:526-534.
24. Scarantino SE, Reilly JG, Moretti ML, Pillari VT. 1999. Argon beam coagulation in the management of placenta accreta. Obstetrics and Gynecology 94:825-827.
25. Schnorr JA, Singer JS, Udoff EJ, Taylor PT. 1999. Late uterine wedge resection of placenta increta. Obstetrics and Gynecology 94:823-825.
26. Th achil J, Toh C.H. 2009. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Reviews 23:167-176.
27. Timmermans S, Van Hof AC, Duvekot JJ. 2007. Conservative management of abnormally invasive placentation. Obstetrical and Gynecological Survey 62:529-539.